Assuring Social Justice for Access to COVID-19 Vaccines: Part 1 Fixing the Broken Disclosure System
October 5, 2020This is Part 1 of a two-part article examining the changes that we need in…
TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)
June 11, 2020This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…
TRIPS, COVID-19, and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 1 of 2)
June 11, 2020This is Part 1 of a two-part article. In response to the COVID-19 pandemic, companies,…
Compulsory Licensing or Patent Pools – What is the Intellectual Property Answer to COVID-19?
June 3, 2020The COVID-19 health emergency has seen different reactions from states in an attempt to curb…
COVID-19 Throws Harsh Spotlight on The Human Cost of Misguided International Trade & IP Policies
May 18, 2020The current global struggle with the Coronavirus pandemic has highlighted dangerous shortcomings of our healthcare…
Compelling Reasonable Access to COVID-19 Treatments under the International Patent System
May 18, 2020There is no guarantee that when effective treatments for the Coronavirus (COVID-19) are found US…
